Aims: To investigate the roles of N-myc downstream-regulated gene 2 (NDRG2) in the pathology of aging and neurodegenerative disease such as Alzheimer's disease (AD).
plaques and NFTs in the brain regions, such as entorhinal cortex and CA1 subregion of the hippocampus known to be vulnerable to AD pathology. 12 However, this initial observation did not explain how NDRG2 level was elevated during AD and what was the role of this protein in AD pathology. These questions remain to be elucidated.
In this study, we verified the abnormal expressions of NDRG2 in various AD animal models and investigated the molecular mechanisms of NDRG2 in AD pathology. Our study demonstrates that the protein NDRG2 affects on multiple pathways contributing the development of the AD-like phenotype and indicates that NDRG2 might be a useful target in study of AD.
| MATERIALS AND METHODS

| Animals
APP/PS1 double-transgenic mice and wild-type littermates were pur- Aβ in the rat and intraperitoneal injection of scopolamine in the mice has been described in previous report. 13, 14 Briefly, Aβ 1-42 peptide was resuspended in DMSO at 5 mmol/L and diluted by cold F12 medium to yield a 100 μmol/L stock solution and then incubated at 4°C for 24 hours. The preparation was then centrifuged at 14 000 g for 10 minutes at 4°C. The supernatants were collected. All experiments were approved and performed in accordance with the institutional guidelines of the Experimental Animal Center of the Chinese Academy of Medical Science, Beijing, China.
| Cell culture
SK-N-SH and SK-N-SH APPwt cells were grown in DMEM, plus
10% fetal bovine serum (Hyclone, Los Angeles, CA, USA), 100 U/mL penicillin/streptomycin. In addition, SK-N-SHAPPwt cells were supplemented with 200 μg/mL G418. Cell cultures were maintained at 37°C in a humidified atmosphere containing 5% CO 2 and passed every 2-4 days based on 85% confluence.
| RNA interference
For NDRG2 knockdown, specific siRNAs for human NDRG2 and negative control were all obtained from Invitrogen (Carlsbad, CA, USA). The short interference RNA sequence is (5′-CCUGGCGAGAUAUGCUCUUTT-3′).
Mixtures of si-NDRG2 and control siRNA were transfected into 
| Western blot analysis
Total protein was extracted using RIPA buffer and determined by the Bradford method (Bradford, 1976) . Samples were run on polyacrylamide gel, transferred on to PVDF membranes, blocked with 5% skim milk, and incubated with primary antibodies overnight at 4°C. After washing with TBST, the membranes were incubated with secondary antibodies (1:10 000) at room temperature for 1 hour. The signals were detected using an enhanced chemiluminescence (ECL) kit, scanned using an LAS3000 Fujifilm imaging system (Fujifilm, Tokyo, Japan), and analyzed by densitometric evaluation using the QuantityOne 4.31software (Bio-Rad, Hercules, CA, USA). The primary antibodies used in this study were listed in Table 1 .
| Immunostaining analysis
Culture cells were grown overnight. The medium was removed, and cells were washed three times with PBS and fixed in 4% paraformaldehyde for 30 minutes. After fixation, cells were thoroughly rinsed with PBS and incubated with goat serum in PBS containing 0.5% Triton X-100 for 2 hours at room temperature. Then, the cells were incubated with an anti-NDRG2 antibody (1:100), an anti-β-catenin antibody (1:100), or an anti-STAT3 antibody (1:100) overnight at 4°C. Then, the cells were 
| Cell viability assay
Cell viability was quantified by its ability to reduce tetrazolium salt 3- ). Primer sequences were as follows: BACE1 (5′-GAGGTATCGACCACTCGC-3′
and 5′-GACTCCACCCGCACAAT-3′) and 18sRNA(5′-CGTCTGCCCT ATCAACTTT-3′ and 5′-TTTCTCAGGCTCCCTCTC-3′).
| NDRG2 subcellular localization analysis
The protein sample isolated from SK-N-SH/SK-N-SH APP695 human neuroblastoma cell was subfractionated into cytosol and nuclear fraction by solubility-based separation and sequential centrifugation using T A B L E 1 Primary antibodies used in this study was added 100 μL ice-cold nuclear extraction buffer, incubated for 5 minutes, and centrifuged at 12 000 g for 5 minutes. The supernatant fraction contained the protein extracted from the nuclei.
| Co-immunoprecipitation
Co-immunoprecipitation was carried out using protein A/G PLUS- 
| Statistical analysis
Statistical analysis of the data was performed with one-way ANOVA using SPSS version 13.0 (SPSS Inc., Chicago, IL, USA). The differences between the groups were analyzed by Bonferroni's post hoc test. For
Western blot analysis, the control group was normalized to 100%. All data were shown as mean±SEM, and prism software (GraphPad Prism 5, La Jolla, CA, USA) was used to draw the picture. A value of P<.05 was considered to be statistically significant.
| RESULTS
| NDRG2 was upregulated in brain tissues of aging and AD animal models
Our previous proteomics study has demonstrated that NDRG2 level was significantly upregulated in the cortex and hippocampus of 15-month-old SAM compared with 5-month-old SAM. 11 To confirm this result, the Western blot analysis was carried out using the tissues of cerebral cortex and hippocampus. A notable increase in NDRG2 level was observed in the hippocampus of 15-month-old SAMR1 as compared to 5-month-old SAMR1 ( Figure 1A ). At the meantime, we found NDRG2 level was also increased in both the cortex and hippocampus of 15-month-old SAMP8 mice compared to 5-month-old SAMP8 ( Figure 1B ). We further explored whether NDRG2 was involved in the process of aging. The result showed that NDRG2 level was significantly enhanced in the cortex of aged rats (24 months) compared to young rats (3 months), although only a slight increase in NDRG2 level was observed in the hippocampus ( Figure 1C ).
The above results suggested that NDRG2 was an aging-related protein, and we hypothesized that NDRG2 might also participate in the pathology of AD. The Aβ 1-42 intracerebroventricular-injected AD rat model was used. NDRG2 level was found upregulated in the cortex and hippocampus of the rats ( Figure 1E ). In addition, similar results were also found in 14-month-old APP/PS1 transgenic mice We then examined the effects of NDRG2 silencing on the level of APP, α-secretase (including ADAM10 and ADAM17), and β-secretase.
We found a marked decrease in BACE1 and Aβ 1-42 levels in siNDRG2 group compared to siControl group, whereas there was no significant difference for the levels of APP, ADAM10, ADAM17, and sAPPα between the two groups ( Figure 2C ).
In the above study, we had demonstrated NDRG2 knockdown alleviating APP metabolism in SK-N-SH APPwt cells. We wondered whether the reciprocal effect could be achieved via NDRG2 overexpression in SK-N-SH cells. For this purpose, we performed a time course study of NDRG2 expression after SK-N-SH cells were transfected with Ad-NDRG2 vector or Ad-lac Z vector. We found that NDRG2 level increased slowly and reached to peak level at 48 hours in Ad-NDRG2 vector transfected cells. At the meantime, we observed a marked increase in BACE1 and Aβ in Ad-NDRG2 group compared to Ad-lac Z group, whereas there were no significant difference for the levels of APP, ADAM10, ADAM17, and sAPPα between the two groups ( Figure 2E ).
| NDRG2 increases BACE1 levels and activity through GGA3-mediated post-translational stabilization
BACE1 cleaves APP at the β-secretase site to initiate the production of Aβ peptides, which constitutes the rate-limiting step of the amyloid production. As we detected a prominent decrease in BACE1 level after NDRG2 knockdown, we wondered whether this reduction was due to the inhibition of transcription. Absolute real-time PCR showed the transcription of BACE1 was unchanged whether in NDRG2 knock- 
| NDRG2 facilitates the hyperphosphorylation of tau
Previous study has demonstrated NDRG2 colocalizes with NFTs in AD cerebral cortex; analysis showed that the level of tau phosphorylation at Ser199, Thr205, Thr231, Ser396, and Ser404 reduced by 77.8%, 64.5%, 76.6%, 54.5%, and 78.3%, respectively, compared to siControl group ( Figure 4B ). Alternatively, these phosphorylation epitopes could be clearly observed after NDRG2 overexpression in SK-N-SH cells, whereas in Ad-lacZ group, they were barely detectable ( Figure 4C ).
| NDRG2 enhanced activity of CDK5 and inhibited the activity of Pin1
Further, we identified the molecular mechanism of NDRG2-mediated tau phosphorylation. We examined the effect of siNDRG2 on the activity of GSK-3β and CDK-5, 17,18 two major kinases for phosphorylation of tau at abundant epitopes. The results showed the level of phosphor-CDK-5(activity form) was obviously reduced in siNDRG2 group compared to siControl group (P<.01) ( Figure 5B ).
Conversely, phosphor-GSK-3β (Ser9) level remained relatively unchanged between the two groups ( Figure 5A ). Meanwhile, phosphor-CDK-5 expression was obviously enhanced in Ad-NDRG2 group, whereas it was very low in Ad-lac Z group ( Figure 5C ). In contrast,
there was no significant difference in phosphor-GSK-3β (Ser9) between the two groups (data not shown). In addition, PP2A (measured by its inactive form phosphor-PP2A Y307) was showed negatively regulated by NDRG2.
The effect of NDRG2 on Pin1 was also studied. Silencing NDRG2 might increase Pin1 expression, and NDRG2 overexpression might Figure 5C ).
| NDRG2 promotes extrinsic caspasedependent apoptosis
NDRG2 was reported as a negative regulator of cell proliferation.
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Therefore, we examined the potential role of NDRG2 to induce cell apoptosis, one of the important pathological changes of AD. 20 The
MTT assays showed the cell viability dramatically increased by 55% in siNDRG2 group compared to siControl group ( Figure 6A ), and cell apoptosis decreased by 68.9% showed by Hoechst staining ( Figure 6C ).
However, overexpression of NDRG2 might increase the apoptosis significantly ( Figure 6D ). The percentage of the apoptotic cells was calculated by the ratio of apoptotic cells to the total cells counted. At least 500 cells were counted from more than three random microscopic fields. Further, it was demonstrated that NDRG2 knockdown attenuating apoptosis was mainly due to a prominent reduction in cleaved caspase-8 and caspase-3 in the cells, indicating NDRG2-mediated cell apoptosis is through the extrinsic apoptotic pathways ( Figure 6E, F) .
| NDRG2 inhibit the activity of STAT3, a mechanism to trig extrinsic apoptosis
As mentioned above, NDRG2-mediated caspase-3 activation was caspase-8-dependent, which is a well-characterized downstream target of Fas ligand-Fas system. Based on this notion, we tested the level of Fasl and Fas in our experiment, and we found both of them were largely downregulated in siNDRG2 group compared to siControl group ( Figure 7A, B) . Up to now, there are several factors that control the expression of Fas. Among them, STAT3 was the most deeply To further elucidate the underlying mechanism of NDRG2-mediated inhibition in STAT3 phosphorylation, we tested STAT3 endogenous inhibitor SOCS3 and MAPK signal pathways, which has been widely studied as a major positive regulator of STAT3 activity. 22, 23 However, no significant differences were observed between siNDRG2 group and siControl group ( Figure 7C ), indicating there might be other mechanism that controlled the NDRG2-medatied STAT3 phosphorylation.
| NDRG2 translocates into the nuclear and interacted with STAT3
Previous studies on the function of NDRG2 in cancer have demon- 
| DISCUSSION
Our previous study demonstrated that NDRG2 protein expression was significantly increased in both cortex and hippocampus of 15-month-old SAM compared to that of 5-month-old SAM, which indicating NDRG2 might be associated with brain aging process.
11
The SAM showed various characteristic age-associated phenotypes, and with a short life span, integrated background information and Quantified results were normalized to β-actin expression. For all the results above, a representative experiment of three performed is shown. Values were expressed as percentages compared to the control group (set to 100%) and represented as group mean±SEM. n=4~5 per group. *P<0.05, **P<0.01 vs control group high repetition rate, it was considered as an ideal model to study the mechanisms of aging or age-related diseases such as AD. 24 In the present study, we showed that NDRG2 protein level was upregulated in the brain tissues of different aging or AD animal models, indicating this protein involved indeed in the pathology of aging or AD. In above models, animals showed cognition deficiency; for example, there was an obvious cognition disorder in the step-down tests of APP/PS1 mice (data are shown as Fig. S1 in Supporting Information). It should be mentioned that in scopolamine intraperitoneal-injected mice model, no significant difference of NDRG2 level was observed, which means it has no relationship with short-term acetylcholine dysfunction.
Early researches of NDRG2 were mainly concentrated on the area of cancer due to the natural prosperity of inhibition of cell proliferation. 25 However, the role of NDRG2 in central nerve system (CNS) has also attracted more and more attention recently. NDRG2 was reported to be upregulated and colocalized with TUNEL-positive cells in ischemic penumbra following transient focal cerebral ischemia, suggesting that NDRG2 may play an important role in cell apoptosis after stroke. 26 In addition, NDRG2 is implicated to be involved in the synaptic transduction and in neurite sprouting, extension, and guidance, which offers novel insights into the physiological roles of NDRG2 in the CNS. 27 Increase in both mRNA and protein levels of NDRG2 was found in the sporadic AD patient. Information). However, our purpose of this study was mainly revealing the role of NDRG2 in neurons during the Alzheimer's disease, so we did not conduct additional studies on astrocytes. In this study, we used human SK-N-SH neuroblastoma cell line overexpressing wt APP695
(APPwt), which is a widely used cell line in the study of AD, and carried out relevant mechanism research of NDRG2.
In this study, we focused on the relationship between NDRG2 and AD pathology, especially the three main characteristics of AD at the molecular level: for example, accumulation of beta-amyloid, abnormal tau phosphorylation, and neuronal apoptosis. 28 Regarding the process half-life of 16 hours, but once it is ubiquitinated at C-terminal Lys501, it could be recognized by GGA3, a key protein for sorting BACE1 to the lysosome for degradation. 29, 30 Our results revealed that NDRG2
was negatively correlated to GGA3 expression and could promote BACE1 trafficking to the endosome, which decreased the degradation of BACE1 and ultimately increased Aβ production in AD.
It is well known that in healthy subjects, tau is a component of microtubules, which represent the internal support structures for transport of nutrients, vesicles, mitochondria and chromosomes within the cell. In AD, tau protein is abnormally hyperphosphorylated, and it might reduce binding affinity to microtubules and result in aberrant tau aggregation into tangles. 31 It has a profound effect on the progression of AD.
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Tau phosphorylation occurs mainly at proline-directed Ser/Thr sites, which are targeted by peptidyl-prolyl cis/trans isomerase 1(Pin1).
Pin1 catalyzes cis to trans prolyl isomerisation of phosphorylated tau, facilitating its dephosphorylation by PP2A and apparently restores the ability to promote microtubules polymerization. Quantified results were normalized to β-actin expression. For all the results above, a representative experiment of three performed is shown. Values were expressed as percentages compared to the control group (set to 100%) and represented as group mean±SEM. n=4~5 per group. *P<0.05, **P<0.01 vs control group correlated with the expression of NDRG2. Our data indicated that CDK5 strongly and positively responded to NDRG2 and PP2A also responded to it. But Pin1 negatively responded to NDRG2; therefore, the phosphorylation of tau was increased in NDRG2 overexpressed cells and decreased in NDRG2 knock-down cells. It was also demonstrated in this study that the signaling pathway of AkT-GSK-3β was not affected by NDRG2, although it was showed to mediate tau phosphorylation in some other cases. Additionally, tau phosphorylation might be also induced by Aβ. Due to the lack of specific Aβ inhibitors, we cannot exclude this possibility in our study.
Neuronal loss by apoptosis is a pathological change during neurodegenerative disorders especially in AD. 34 Therefore, explicating the mechanisms of neuronal apoptosis during AD is critical for elucidating the pathophysiology of the disease. In this study, we demonstrated that NDRG2 was strongly related to apoptosis of SK-N-SH APPwt cells as it was reported in cancer previously. It was found that NDRG2-induced cell death was not through the mitochondria-cytochrome c pathway, but through the death receptor apoptotic pathway by highly expressed Fas-Fasl system and consequently boosting caspase-8-dependent caspase-3 activation.
The Fas/Fasl expression is mainly modulated by STAT3. In our experiments, we observed NDRG2 primarily localized to the cytoplasm of SK-N-SH cells, whereas in SK-N-SH APPswe cells, NDRG2 significantly translocated into the nucleus. Furthermore, we found NDRG2
interacted with STAT3 in SK-N-SH APPwt nucleus, while in SK-N-SH cells, this interaction was barely observed. We speculate that the colocalization of NDRG2 and STAT3 in the nucleus may affect the transcription activity of STAT3 for the target genes like Fas. Our result is in line with a previous study, which elucidated NDRG2 moved from cytosol to nucleus to form the complex with MSP58 upon cell stress and inhibited MSP58-induced cell proliferation. 35 However, the mechanisms of APP-mediated NDRG2 translocation into nucleus as well as the interaction between NDRG2 and STAT3 need to be studied in the future. Our data suggested that although some clear pathological roles of NDRG2 were showed in this study, we cannot exclude the possibility that cell apoptosis and tau phosphorylation induced by NDRG2 might be attributed to increased Aβ production. It has been reported that Aβ induced cell apoptosis and tau phosphorylation. 25, 36 Due to lack of specific Aβ inhibitor, the role of Aβ in NDRG2-induced neuronal apoptosis and tau phosphorylation could not be ignored. In addition,
we demonstrated that NDRG2 might directly affect the activities of CDK5, an important enzyme for phosphorylation of tau. However, the effects of Aβ on CDK5 could not be ruled out because Aβ can also increase the activity of CDK5. 37 Therefore, the pathological effects of NDRG2 in AD might be indirect through the increased Aβ, whereas the distinct pathway of NDRG2-induced cell apoptosis by enhancing expression and function of Fas/FasI system was found in this study.
In conclusion, we have investigated the pathophysiological roles and mechanisms of NDRG2 in AD animal and cell models. 
